Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH.
Moon JH, et al. Among authors: ha sh.
Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4.
Br J Cancer. 2019.
PMID: 30944457
Free PMC article.